Kendall Healthcare-B (02216): Core product BroncAblate IntelliBalance lung radiofrequency ablation system mainframe approved for market launch in China.

The Chitoo Finance APP news, Kunbo Medical-B (02216) announced that following the approval of the BroncAblate SmartBalance Disposable Pulmonary Radiofrequency Ablation Catheter (National Medical Device Registration No. 20253010767) in China, the core product of the company, the independently developed BroncAblate SmartBalance Pulmonary Radiofrequency Ablation System main unit (National Medical Device Registration No. 20253011204) has officially been approved for marketing by the National Medical Products Administration (NMPA) of China. With this approval, the BroncAblate SmartBalance Pulmonary Radiofrequency Ablation System, the world's first natural cavity (bronchus) radiofrequency ablation device for lung cancer treatment, has entered the commercialization process.